Best Clean Energy Stocks To Own For 2019

tags:NBD,OCLR,IQI,AVXL,

China is home to some of the most polluted cities in the world, as they choke on dirty air. Its rivers are renowned as the home for deadly chemicals. Apple Inc. (NASDAQ: AAPL) wants to end some of that and plans to pay to do so.

Apple plans to get some of its suppliers to foot much of the bill for its China Green Energy Fund, which will eventually grow close to $300 million. Among the suppliers are Catcher Technology, Compal Electronics, Corning, Golden Arrow, Jabil, Luxshare-ICT, Pegatron, Solvay, Sunway Communication and Wistron. It is not clear what each will put into the fund, or if Apple supplies most of the money.

The scale of the plan seems large at $300 million, but on the kind of scale China represents, the investment is minimal. Apple management wrote:

The fund will invest in and develop clean energy projects totaling more than 1 gigawatt of renewable energy in China, the equivalent of powering nearly 1 million homes.

China has over 1.3 billion residents and hundreds of millions of households. A study by 24/7 Wall St. showed that many of the 25 most polluted cities in the world are in China. Part of the research came from the World Health Organization. Research shows that air pollution kills as many as a million people in China each year.

Best Clean Energy Stocks To Own For 2019: Nuveen Build America Bond Opportunity Fund(NBD)

Advisors' Opinion:

• [By Shane Hupp]

  Media coverage about Nuveen Build America Bond Opp Fund (NYSE:NBD) has been trending somewhat positive on Monday, according to Accern Sentiment. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Nuveen Build America Bond Opp Fund earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave media headlines about the company an impact score of 47.5135821966095 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

• [By Stephan Byrd]

  Media stories about Nuveen Build America Bond Opp Fund (NYSE:NBD) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Build America Bond Opp Fund earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave media stories about the company an impact score of 47.3636708987454 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Best Clean Energy Stocks To Own For 2019: Oclaro, Inc.(OCLR)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Oclaro (OCLR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday. Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday. NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors. Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15. NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading. Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday. Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday. Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday. Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading. TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday. CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading. Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading. International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading. Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday. Finisar
• [By Shane Hupp]

  Oclaro (NASDAQ:OCLR) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  Pra Group (NASDAQ:PRAA) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

• [By Shane Hupp]

  Thompson Siegel & Walmsley LLC reduced its stake in Oclaro Inc. (NASDAQ:OCLR) by 58.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,246,272 shares of the semiconductor company’s stock after selling 1,729,354 shares during the period. Thompson Siegel & Walmsley LLC owned approximately 0.74% of Oclaro worth $11,914,000 as of its most recent filing with the Securities and Exchange Commission.

• [By Peter Graham]

  Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is the most shorted stock on the NASDAQ with short interest of 62.65% according to Highshortnterest.com.

Best Clean Energy Stocks To Own For 2019: Invesco Quality Municipal Income Trust(IQI)

Advisors' Opinion:

• [By Ethan Ryder]

  Press coverage about Invesco Quality Municipal Income Trust (NYSE:IQI) has been trending positive on Tuesday, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Invesco Quality Municipal Income Trust earned a news impact score of 0.30 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 47.8100034187875 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

• [By Shane Hupp]

  Invesco Quality Municipal Income Trust (NYSE:IQI) announced a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Investors of record on Tuesday, October 16th will be paid a dividend of 0.0574 per share by the financial services provider on Wednesday, October 31st. This represents a $0.69 dividend on an annualized basis and a yield of 6.14%. The ex-dividend date is Monday, October 15th.

• [By Shane Hupp]

  Laurion Capital Management LP increased its stake in Invesco Quality Municipal Income Trust (NYSE:IQI) by 157.4% in the second quarter, Holdings Channel reports. The institutional investor owned 111,867 shares of the financial services provider’s stock after acquiring an additional 68,404 shares during the quarter. Laurion Capital Management LP’s holdings in Invesco Quality Municipal Income Trust were worth $1,333,000 as of its most recent SEC filing.

Best Clean Energy Stocks To Own For 2019: Anavex Life Sciences Corp.(AVXL)

Advisors' Opinion:

• [By Joseph Griffin]

  Anavex Life Sciences (NASDAQ:AVXL) and Icon (NASDAQ:ICLR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

• [By Joseph Griffin]

  News stories about Anavex Life Sciences (NASDAQ:AVXL) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Anavex Life Sciences earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news headlines about the biotechnology company an impact score of 46.1730416635586 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

• [By Stephan Byrd]

  Schwab Charles Investment Management Inc. lifted its stake in Anavex Life Sciences Corp (NASDAQ:AVXL) by 48.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,200 shares of the biotechnology company’s stock after purchasing an additional 25,000 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Anavex Life Sciences were worth $211,000 at the end of the most recent quarter.

• [By Shane Hupp]

  Here are some of the media stories that may have effected Accern’s analysis:

  Get Anavex Life Sciences alerts: Comparing Anavex Life Sciences (AVXL) & Viralytics (VRACY) (americanbankingnews.com) Hot Move to Watch Anavex Life Sciences Corp. (AVXL) (nasdaqplace.com) Anavex Life Sciences (AVXL) and Intrexon (XON) Head to Head Review (americanbankingnews.com) -$0.10 EPS Expected for Anavex Life Sciences (AVXL) This Quarter (americanbankingnews.com)

  A number of equities analysts recently issued reports on the stock. Maxim Group reaffirmed a “buy” rating and set a $7.00 target price (up previously from $5.00) on shares of Anavex Life Sciences in a research report on Thursday, May 31st. Zacks Investment Research lowered shares of Anavex Life Sciences from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Noble Financial set a $7.00 target price on shares of Anavex Life Sciences and gave the stock a “buy” rating in a research report on Wednesday, May 16th. HC Wainwright assumed coverage on shares of Anavex Life Sciences in a research report on Wednesday, May 30th. They set a “buy” rating and a $10.00 target price on the stock. Finally, Roth Capital initiated coverage on shares of Anavex Life Sciences in a research report on Thursday, March 8th. They set a “buy” rating and a $6.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Anavex Life Sciences presently has an average rating of “Buy” and an average target price of $6.55.

• [By Shane Hupp]

  Anavex Life Sciences (NASDAQ:AVXL)’s share price shot up 4.8% during mid-day trading on Tuesday . The company traded as high as $4.35 and last traded at $3.93. 14,995 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 606,708 shares. The stock had previously closed at $4.13.